Enanta Pharmaceuticals (ENTA) Change in Accured Expenses (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Change in Accured Expenses of -$716000.0 for Q1 2026, up 63.71% year-on-year from -$437358.5 in Q1 2025, and up 86.17% on a QoQ basis from -$5.2 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Change in Accured Expenses data on file, last reported at -$716000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 63.71% year-over-year to -$716000.0; the trailing twelve-month figure through Mar 2026 stood at -$951000.0 (up 66.28% YoY), and the FY2025 full-year result was $58000.0, up 101.03% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$716000.0, up from -$5.2 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.7 million in Q2 2023 and bottomed at -$6.7 million in Q4 2023.
- The 5-year median for Change in Accured Expenses is -$716000.0 (2026), against an average of -$1.2 million.
- The widest annual swing landed in 2024, when Change in Accured Expenses plunged 277.88%; it then surged 502.99% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at -$6.6 million in 2022, then declined by 2.08% to -$6.7 million in 2023, then jumped by 56.8% to -$2.9 million in 2024, then tumbled by 77.87% to -$5.2 million in 2025, then soared by 86.17% to -$716000.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$716000.0 (Q1 2026), -$5.2 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -716,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -716,000.00 |
| Mar 31, 2026 | -716,000.00 |
| Dec 31, 2025 | -5.18 Mn |
| Dec 31, 2025 | -5.18 Mn |
| Sep 30, 2025 | 2.42 Mn |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | -1.97 Mn |
| Mar 31, 2025 | -1.97 Mn |
| Dec 31, 2024 | -2.91 Mn |
| Dec 31, 2024 | -2.91 Mn |
| Sep 30, 2024 | 401,000.00 |
| Sep 30, 2024 | 401,000.00 |
| Jun 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | -973,000.00 |
| Mar 31, 2024 | -973,000.00 |
| Dec 31, 2023 | -6.74 Mn |
| Dec 31, 2023 | -6.74 Mn |
| Sep 30, 2023 | 792,000.00 |
| Sep 30, 2023 | 792,000.00 |
| Jun 30, 2023 | 2.70 Mn |
| Jun 30, 2023 | 2.70 Mn |
| Mar 31, 2023 | 547,000.00 |
| Mar 31, 2023 | 547,000.00 |
| Dec 31, 2022 | -6.60 Mn |
| Dec 31, 2022 | -6.60 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Jun 30, 2022 | -2.45 Mn |
| Jun 30, 2022 | -2.45 Mn |
| Mar 31, 2022 | -5.01 Mn |
| Mar 31, 2022 | -5.01 Mn |
| Dec 31, 2021 | 4.21 Mn |
| Dec 31, 2021 | 4.21 Mn |
| Sep 30, 2021 | 4.68 Mn |
| Sep 30, 2021 | 4.68 Mn |
| Jun 30, 2021 | 1.97 Mn |
| Jun 30, 2021 | 1.97 Mn |
| Mar 31, 2021 | 4.20 Mn |
| Mar 31, 2021 | 4.20 Mn |
| Dec 31, 2020 | -2.50 Mn |
| Dec 31, 2020 | -2.50 Mn |
| Sep 30, 2020 | 568,000.00 |
| Sep 30, 2020 | 568,000.00 |
| Jun 30, 2020 | 3.65 Mn |
| Jun 30, 2020 | 3.65 Mn |
| Mar 31, 2020 | 404,000.00 |
| Mar 31, 2020 | 404,000.00 |
| Dec 31, 2019 | -5.99 Mn |
| Dec 31, 2019 | -5.99 Mn |
| Sep 30, 2019 | 1.79 Mn |
| Sep 30, 2019 | 1.79 Mn |
| Jun 30, 2019 | 2.70 Mn |
| Jun 30, 2019 | 2.70 Mn |
| Mar 31, 2019 | 661,000.00 |
| Mar 31, 2019 | 661,000.00 |
| Dec 31, 2018 | 598,000.00 |
| Dec 31, 2018 | 598,000.00 |
| Sep 30, 2018 | 693,000.00 |
| Sep 30, 2018 | 693,000.00 |
| Jun 30, 2018 | 2.09 Mn |
| Jun 30, 2018 | 2.09 Mn |
| Mar 31, 2018 | 1.56 Mn |
| Mar 31, 2018 | 1.56 Mn |
| Dec 31, 2017 | -2.49 Mn |
| Dec 31, 2017 | -2.49 Mn |
| Sep 30, 2017 | 2.30 Mn |
| Sep 30, 2017 | 2.30 Mn |
| Jun 30, 2017 | 583,000.00 |
| Jun 30, 2017 | 583,000.00 |
| Mar 31, 2017 | 572,000.00 |
| Mar 31, 2017 | 572,000.00 |
| Dec 31, 2016 | -10,000.00 |
| Dec 31, 2016 | -10,000.00 |
| Sep 30, 2016 | -88,000.00 |
| Sep 30, 2016 | -88,000.00 |
| Jun 30, 2016 | 2.28 Mn |
| Jun 30, 2016 | 2.28 Mn |
| Mar 31, 2016 | -480,000.00 |
| Mar 31, 2016 | -480,000.00 |
| Dec 31, 2015 | 150,000.00 |
| Dec 31, 2015 | 150,000.00 |
| Sep 30, 2015 | -618,000.00 |
| Sep 30, 2015 | -618,000.00 |
| Jun 30, 2015 | 782,000.00 |
| Jun 30, 2015 | 782,000.00 |
| Mar 31, 2015 | 84,000.00 |
| Mar 31, 2015 | 84,000.00 |
| Dec 31, 2014 | -475,000.00 |
| Dec 31, 2014 | -475,000.00 |
| Sep 30, 2014 | 17,000.00 |
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 518,000.00 |
| Jun 30, 2014 | 518,000.00 |
| Mar 31, 2014 | 599,000.00 |
| Mar 31, 2014 | 599,000.00 |
| Dec 31, 2013 | -1.32 Mn |
| Dec 31, 2013 | -1.32 Mn |
| Sep 30, 2013 | 1.00 Mn |
| Sep 30, 2013 | 1.00 Mn |
| Jun 30, 2013 | 81,000.00 |
| Jun 30, 2013 | 81,000.00 |
| Mar 31, 2013 | 707,000.00 |
| Mar 31, 2013 | 707,000.00 |
| Dec 31, 2012 | -2.08 Mn |
| Dec 31, 2012 | -2.08 Mn |
| Sep 30, 2012 | 725,000.00 |
| Sep 30, 2012 | 725,000.00 |
| Jun 30, 2012 | 862,000.00 |
| Jun 30, 2012 | 862,000.00 |